At the news
? NEUTRALIMPACT 1/10 144 filed Jun 11, 2026 at 17:09 ET
Director Roger Jeffs filed a Form 144 to sell 286 shares of Axsome Therapeutics common stock, valued at approximately $70,407. The shares originated from a restricted stock lapse on June 6, 2026, and the sale appears to be a routine tax-withholding transaction. The dollar amount is negligible relative to the company's $12.7B market cap, making this filing inconsequential for traders.
- Director Roger Jeffs filed Form 144 to sell 286 shares of common stock.
- Estimated sale value of $70,407 based on June 10, 2026 trade.
- Shares originated from a restricted stock lapse (equity compensation) on June 6, 2026.
- Sale constitutes a trivial fraction of the company's $12.7B market capitalization.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access